Hajime Kashima

1.3k total citations
42 papers, 959 citations indexed

About

Hajime Kashima is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hajime Kashima has authored 42 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hajime Kashima's work include Gastric Cancer Management and Outcomes (7 papers), Cancer Cells and Metastasis (6 papers) and Cancer Research and Treatments (6 papers). Hajime Kashima is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Cancer Cells and Metastasis (6 papers) and Cancer Research and Treatments (6 papers). Hajime Kashima collaborates with scholars based in Japan, United States and China. Hajime Kashima's co-authors include Toshiyoshi Fujiwara, Kazuhiro Noma, Takuya Kato, Hiroshi Tazawa, Yasuhiro Shirakawa, Toshiaki Ohara, Ryoichi Katsube, Satoshi Komoto, Hiroaki Sato and Yuki Katsura and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

In The Last Decade

Hajime Kashima

31 papers receiving 944 citations

Peers

Hajime Kashima

ONCOL

IMMUN

Jieyi Wang United States

Shalini Sethumadhavan United States

Masaki Nogawa Japan

Alexei V. Salnikov Germany

Oksana Nemirovsky Canada

Samuele Cazzamalli Switzerland

Elodie Viry Luxembourg

Wells S. Brown United States

Jelena Grahovac Serbia

Jieyi Wang United States

Hajime Kashima

662 ×1.2

ONCOL

407 ×1.4

372 ×1.6

IMMUN

143 ×0.8

144 ×0.9

Citations per year, relative to Hajime Kashima Hajime Kashima (= 1×) peers Jieyi Wang

Countries citing papers authored by Hajime Kashima

Since Specialization

Citations

This map shows the geographic impact of Hajime Kashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajime Kashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajime Kashima more than expected).

Fields of papers citing papers by Hajime Kashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajime Kashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajime Kashima. The network helps show where Hajime Kashima may publish in the future.

Co-authorship network of co-authors of Hajime Kashima

This figure shows the co-authorship network connecting the top 25 collaborators of Hajime Kashima. A scholar is included among the top collaborators of Hajime Kashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajime Kashima. Hajime Kashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kakiuchi, Yoshihiko, Nobuhiko Kanaya, Hajime Kashima, et al.. (2025). Neoadjuvant chemotherapy strategies for optimizing safety and efficacy in elderly patients with locally advanced gastric cancer. BMC Gastroenterology. 25(1). 670–670.

Kakiuchi, Yoshihiko, Nobuhiko Kanaya, Hajime Kashima, et al.. (2025). Gallbladder edema as a clue to zolbetuximab-associated protein-losing enteropathy in gastric cancer: a case report. Gastric Cancer. 28(6). 1297–1301.

Kanaya, Nobuhiko, Shinji Kuroda, Hajime Kashima, et al.. (2025). Short-Term and Long-Term Outcomes of Robotic Gastrectomy for Gastric Cancer: A Single-Center, Single-Arm Prospective Study. Cureus. 17(2). e79063–e79063.

Kobayashi, Teruki, Kazuhiro Noma, Takuya Kato, et al.. (2024). Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody. Molecular Cancer Therapeutics. 23(7). 1031–1042. 7 indexed citations

Kikuchi, Satoru, et al.. (2024). Effect of Oral Nutritional Supplements Composed of High Protein on Body Weight Loss After Gastrectomy. In Vivo. 39(1). 426–432.

Kashima, Hajime, Vered Gazit, Changqing Ma, et al.. (2024). A Novel CRISPR/Cas9-mediated Mouse Model of Colon Carcinogenesis. Cellular and Molecular Gastroenterology and Hepatology. 18(5). 101390–101390. 2 indexed citations

Noma, Kazuhiro, Takuya Kato, Kento Kawasaki, et al.. (2024). Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity. British Journal of Cancer. 130(10). 1647–1658. 18 indexed citations

Kakiuchi, Yoshihiko, Yusuke Yoshida, Nobuhiko Kanaya, et al.. (2024). An effective surgical educational system in the era of robotic surgery: “Double-Surgeon Technique” in robotic gastrectomy for minimally invasive surgery. Langenbeck s Archives of Surgery. 410(1). 20–20.

Kanaya, Nobuhiko, Yoshitaka Kondo, Yoshihiko Kakiuchi, et al.. (2024). Primary ileal myeloid sarcoma presenting with bowel obstruction: a case report. Surgical Case Reports. 10(1). 229–229. 1 indexed citations

10.

Kikuchi, Satoru, Takashi Matsusaki, Toshiharu Mitsuhashi, et al.. (2024). Epidural versus patient-controlled intravenous analgesia on pain relief and recovery after laparoscopic gastrectomy for gastric cancer: randomized clinical trial. BJS Open. 8(1). 1 indexed citations

11.

Komoto, Satoshi, Kazuhiro Noma, Takuya Kato, et al.. (2023). Conventional Cancer Therapies Can Accelerate Malignant Potential of Cancer Cells by Activating Cancer-Associated Fibroblasts in Esophageal Cancer Models. Cancers. 15(11). 2971–2971. 1 indexed citations

12.

Noma, Kazuhiro, Toshiaki Ohara, Kento Kawasaki, et al.. (2023). Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody. Cancer Immunology Immunotherapy. 72(7). 2029–2044. 16 indexed citations

13.

Kashima, Hajime, et al.. (2023). The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer. American Journal of Physiology-Gastrointestinal and Liver Physiology. 325(2). G196–G211.

14.

Kashima, Hajime, Satoru Kikuchi, Shinji Kuroda, & Toshiyoshi Fujiwara. (2023). Laparoscopic and Endoscopic Cooperative Surgery for Gastric Submucosal Tumor Near Esophagogastric Junction With Sliding Hiatal Hernia. Cureus. 15(4). e37902–e37902.

15.

Shirakawa, Yasuhiro, Hiroshi Tazawa, Shunsuke Tanabe, et al.. (2021). Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments. European Journal of Cancer. 153. 98–108. 49 indexed citations

16.

Katsube, Ryoichi, Kazuhiro Noma, Toshiaki Ohara, et al.. (2021). Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer. Scientific Reports. 11(1). 1693–1693. 62 indexed citations

17.

Kato, Takuya, Kazuhiro Noma, Toshiaki Ohara, et al.. (2018). Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor Microenvironment. Clinical Cancer Research. 24(19). 4820–4833. 276 indexed citations

18.

Noma, Kazuhiro, Hajime Kashima, Takayuki Ninomiya, et al.. (2015). [Therapeutic Potential of Targeting Cancer-Associated Fibroblasts in Esophageal Cancer].. PubMed. 42(10). 1228–30. 1 indexed citations

19.

Kashima, Hajime, et al.. (2014). A Case of Breast Cancer Metastasis in Bone Marrow for which Weekly Paclitaxel was Effective. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 75(1). 34–39.

20.

Hagihara, Koji, Hajime Kashima, Junichi Enokizono, et al.. (2007). Novel 4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)methylbenzofuran derivatives as selective α2C-adrenergic receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(6). 1616–1621. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact